Showing 561-580 of 7110 for: Cochrane Systematic Reviews Back
- Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Cochrane Systematic Reviews, 11-Mar-2016
People with haematological disorders are frequently at risk of severe or life-threatening bleeding as a result of thrombocytopenia (reduced platelet count). This is despite the routine use of prophylactic platelet transfusions to prevent bleeding once the
- Antifibrinolytics for heavy menstrual bleeding
Cochrane Systematic Reviews, 20-Sep-2010
Heavy menstrual bleeding (HMB) is an important cause of ill health in women. Medical therapy, with the avoidance of possibly unnecessary surgery, is an attractive treatment option. A wide variety of medications are available to reduce heavy menstrual blee
- Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients
Cochrane Systematic Reviews, 15-Jan-2016
Invasive fungal infections are important causes of morbidity and mortality among critically ill patients. Early institution of antifungal therapy is pivotal for mortality reduction. Starting a targeted antifungal therapy after culture positivity and fungi
- Antifungal agents for preventing fungal infections in solid organ transplant recipients
Cochrane Systematic Reviews, 12-May-2009
Invasive fungal infections (IFIs) are important causes of morbidity and mortality in solid organ transplant recipients.
- Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV
Cochrane Systematic Reviews, 10-Nov-2008
Cryptococcal disease is an opportunistic infection that causes significant morbidity and mortality in adults with HIV. Primary prophylaxis with antifungal interventions may decrease cryptococcal disease incidence and associated mortality.
- Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
Cochrane Systematic Reviews, 2-Sep-2022
Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction to colonisation of the lungs with the fungus Aspergillus fumigatus, and affects around 10% of people with cystic fibrosis. ABPA is associated with an accelerated decline in lung functi
- Antifungal therapy for newborn infants with invasive fungal infection
Cochrane Systematic Reviews, 15-May-2012
A variety of antifungal drugs, drug preparations and drug combinations are available to treat newborn infants with suspected or confirmed invasive fungal infection. There is a need to assess their relative merits.
- Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections
Cochrane Systematic Reviews, 11-Feb-2015
Invasive fungal infections are associated with significant morbidity and mortality in children. Optimal treatment strategies are yet to be defined.
- Anti‐GD2 antibody‐containing immunotherapy postconsolidation therapy for people with high‐risk neuroblastoma treated with autologous haematopoietic stem cell transplantation
Cochrane Systematic Reviews, 24-Apr-2019
Neuroblastoma is a rare malignant disease that primarily affects children. The tumours mainly develop in the adrenal medullary tissue, and an abdominal mass is the most common presentation. High-risk disease is characterised by metastasis and other primar
- Antigen-specific active immunotherapy for ovarian cancer
Cochrane Systematic Reviews, 10-Sep-2014
Despite advances in chemotherapy, prognosis of ovarian cancer remains poor. Antigen-specific active immunotherapy aims to induce tumour-antigen-specific anti-tumour immune responses as an alternative treatment for ovarian cancer.
- Antiglucocorticoid and related treatments for psychosis
Cochrane Systematic Reviews, 16-Dec-2015
Hypothalamic-pituitary-adrenal (HPA) axis dysregulation has been implicated in the development and relapse of psychotic disorders. Elevated cortisol secretion has been positively linked with symptom severity in people with psychosis. Antiglucocorticoid an
- Antiglucocorticoid treatments for mood disorders
Cochrane Systematic Reviews, 4-Dec-2015
Antiglucocorticoids may have antidepressant effects and have been reported to be efficacious in the treatment of severe psychiatric disorders. The efficacy and safety of antiglucocorticoid treatments for mood disorders is the subject of this systematic re
- Antihistamines and/or decongestants for otitis media with effusion (OME) in children
Cochrane Systematic Reviews, 18-Jul-2011
This is an update of a Cochrane Review first published in The Cochrane Library in Issue 4, 2006.
- Antihistamines for motion sickness
Cochrane Systematic Reviews, 17-Oct-2022
Motion sickness is a syndrome that occurs as a result of passive body movement in response to actual motion, or the illusion of motion when exposed to virtual and moving visual environments. The most common symptoms are nausea and vomiting. Antihistamines
- Anti-histamines for prolonged non-specific cough in children
Cochrane Systematic Reviews, 19-Nov-2009
Non-specific cough is defined as non-productive cough in the absence of identifiable respiratory disease or known aetiology. It is commonly seen in paediatric practice. These children are treated with a variety of therapies including anti-histamines. Also
- Antihistamines for the common cold
Cochrane Systematic Reviews, 21-Jul-2009
Although antihistamines are prescribed in large quantities for the common cold, there is little evidence as to whether these drugs are effective.
- Antihistamines for the common cold
Cochrane Systematic Reviews, 29-Nov-2015
The common cold is an upper respiratory tract infection, most commonly caused by a rhinovirus. It affects people of all age groups and although in most cases it is self limiting, the common cold still causes significant morbidity. Antihistamines are commo
- Antihistamines used in addition to topical nasal steroids for intermittent and persistent allergic rhinitis in children
Cochrane Systematic Reviews, 14-Jun-2010
Allergic rhinitis is a very common chronic illness affecting 10% to 40% of children worldwide and its prevalence among children has significantly increased over the last two decades. Prevalence and severity are related to age, with children of school age
- Antihypertensive agents for preventing diabetic kidney disease
Cochrane Systematic Reviews, 20-Aug-2013
Various blood pressure-lowering agents, and particularly inhibitors of the renin-angiotensin system (RAS), are widely used for people with diabetes to prevent the onset of diabetic kidney disease (DKD) and adverse cardiovascular outcomes. This is an updat
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
Cochrane Systematic Reviews, 29-Jan-2014
Mild to moderate hypertension during pregnancy is common. Antihypertensive drugs are often used in the belief that lowering blood pressure will prevent progression to more severe disease, and thereby improve the outcome.
